
IHC image of CSB-PA717453LA01HU diluted at 1:800 and staining in paraffin-embedded human gastric cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
RNF213 Antibody
CSB-PA717453LA01HU
ApplicationsImmunoFluorescence, ELISA, ImmunoHistoChemistry
Product group Antibodies
TargetRNF213
Overview
- SupplierCusabio
- Product NameRNF213 Antibody
- Delivery Days Customer20
- ApplicationsImmunoFluorescence, ELISA, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID57674
- Target nameRNF213
- Target descriptionring finger protein 213
- Target synonymsALK lymphoma oligomerization partner on chromosome 17; ALO17; C17orf27; E3 ubiquitin-protein ligase RNF213; KIAA1618; MYMY2; mysterin; MYSTR; NET57; RING-type E3 ubiquitin transferase RNF213
- HostRabbit
- IsotypeIgG
- Protein IDQ63HN8
- Protein NameE3 ubiquitin-protein ligase RNF213
- Scientific DescriptionE3 ubiquitin-protein ligase involved in angiogenesis (PubMed:21799892, PubMed:26278786, PubMed:26766444, PubMed:26126547). Involved in the non-canonical Wnt signaling pathway in vascular development: acts by mediating ubiquitination and degradation of FLNA and NFATC2 downstream of RSPO3, leading to inhibit the non-canonical Wnt signaling pathway and promoting vessel regression (PubMed:26766444). Also has ATPase activity (PubMed:24658080, PubMed:26126547).
- Storage Instruction-20°C or -80°C
- UNSPSC12352203